Hologic Inc. (NSDQ:HOLX) acquired Interlace Medical Inc. and its minimally invasive fibroid treatment for $125 million, saying it hopes to have Interlace’s MyoSure system on the market early this year.
The Pritzker Group acquired medical device maker Clinical Innovations for an undisclosed amount.
It’s the first foray into healthcare for the Chicago-based private investment firm, which uses the vast fortune of the Pritzker family to fund its activities. The group bought Murray, Utah-based Clinical Innovations from private equity player RoundTable Health Partners.
Natus Medical Inc. (NSDQ:BABY) bought out newborn baby care device maker Medix.
The San Carlos, Calif.-based children’s medical products maker paid $14 million in cash for the company, but the price could rise if certain revenue milestones are met in 2011 and 2012.
Hologic Inc. (NSDQ:HOLX) won a round in its patent infringement battle with Conceptus Inc. (NSDQ:CPTS) after a federal judge ruled that Hologic can use a letter Conceptus claimed was covered under attorney-client privilege.
Mountain View, Calif.-based Conceptus sued its Bedford, Mass.-based competitor in May 2009, alleging infringement of five patents covering its Essure female sterilization system.
Spanish doctors developed a new treatment for endometrial cancer that prolongs fertility and has fewer side effects than similar treatments, according to a report published in the Annals of Oncology.
The study showed that an intrauterine device that releases the progesterone-like hormone levonorgestrel, when paired with gonadotropin-releasing hormone, is effective at halting and reversing the growth of the uterine cancers.
Hologic Inc. (NSDQ:HOLX) won a $32.3 million contract with the U.S. Dept. of Defense for its pap tests and supplies related to the kits, while Henry Schein Inc. (NSDQ:HSIC) landed a $28.8 million deal for general dental supplies.
Bedford, Mass.-based Hologic was the only bidder for its year-long contract, which calls for it to supply the the Army, Navy, Air Force and Marine Corps with its ThinPrep test kits for human papilloma virus, according to the Defense Dept.
Conceptus Inc. (NSDQ:CPTS) and Hologic Inc. (NSDQ:HOLX) agreed to narrow the scope of a patent infringement lawsuit over their respective female sterilization treatments, dropping all unfair competition claims and counter-claims from the case.
Mountain View, Calif.-based Conceptus sued its Bedford, Mass.-based competitor in May 2009, alleging infringement of five patents for its Essure female sterilization system.
Hologic Inc. (NSDQ:HOLX) fought back against rival Conceptus Inc. (NSDQ:CPTS) in a lawsuit accusing Conceptus of falsely marking one of its products with patents owned by Hologic.
The lawsuit, filed in the U.S. District Court for Massachusetts, accuses Conceptus of marking its Essure female sterilization system as protected by two patents covering Hologic’s competing Adiana system.
Hologic Inc. (NSDQ:HOLX) closed its $85 million acquisition of Sentinelle Medical Inc. and its line of MRI breast coils, tables and visualization software.
The Bedford, Mass.-based company announced the deal in July, saying it would pay a "two-year contingent earn out" on top of the 85 large for Toronto-based company.
Problem: 50 premature or sick newborns to feed, up to eight times a day, with their own mothers’ breast milk.
Solution: SafeBaby BMT.
For Paragon Data Systems Inc. in Cleveland, keeping track of breast milk was a complex inventory problem, said Larry Laurenzi, Paragon’s president.
So two years ago, the bar code systems integrator began devising a system to track bottles and syringes of breast milk in neonatal and pediatric intensive care units.
The Israeli subsidiary of Simbionix USA and a Florida medical school have received a grant of an unspecified amount to develop a laparoscopic hysterectomy surgery simulator.
The grant comes from the U.S.-Israel Binational Industrial Research and Development Foundation, which promotes technology collaborations between companies and organizations from the two countries.